China Brachytherapy Market Size & Outlook, 2020-2028
China brachytherapy market, 2017-2028 (US$M)
Related Markets
China brachytherapy market highlights
- The China brachytherapy market generated a revenue of USD 45.4 million in 2020 and is expected to reach USD 82.0 million by 2028.
- The China market is expected to grow at a CAGR of 7.7% from 2021 to 2028.
- In terms of segment, high-dose rate (hdr) brachytherapy was the largest revenue generating dosage type in 2020.
- Low-Dose Rate (LDR) Brachytherapy is the most lucrative dosage type segment registering the fastest growth during the forecast period.
Brachytherapy market data book summary
| Market revenue in 2020 | USD 45.4 million |
| Market revenue in 2028 | USD 82.0 million |
| Growth rate | 7.7% (CAGR from 2020 to 2028) |
| Largest segment | High-dose rate (hdr) brachytherapy |
| Fastest growing segment | Low-Dose Rate (LDR) Brachytherapy |
| Historical data | 2017 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | High-Dose Rate (HDR) Brachytherapy, Low-Dose Rate (LDR) Brachytherapy |
| Key market players worldwide | Siemens Healthineers AG ADR, Becton Dickinson & Co, Elekta AB ADR, Icad Inc, Roper Technologies Inc, Ustar, IsoRay, Eckert & Ziegler Bebig SA |
Other key industry trends
- In terms of revenue, China accounted for 5.8% of the global brachytherapy market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, China brachytherapy market is projected to lead the regional market in terms of revenue in 2028.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 29.6 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Brachytherapy Market Scope
Brachytherapy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China brachytherapy market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to brachytherapy market will help companies and investors design strategic landscapes.
High-dose rate (hdr) brachytherapy was the largest segment with a revenue share of 68.5% in 2020. Horizon Databook has segmented the China brachytherapy market based on high-dose rate (hdr) brachytherapy, low-dose rate (ldr) brachytherapy covering the revenue growth of each sub-segment from 2017 to 2028.
China was the largest revenue generating region in Asia Pacific in 2018 owing to factors such as wide usage of HDR brachytherapy, introduction of new technologies, and presence of large target population.
For instance, in 2017, iCAD, a New Hampshire medical device manufacturer, received CFDA approval for its product Xoft Axxent balloon applicators, which is indicated in brachytherapy treatment of breast cancer.
Furthermore, manufacturers such as Elekta is organizing workshops and learning centers in China to raise awareness regarding treatment, which is likely to further drive the market growth in the country.
Reasons to subscribe to China brachytherapy market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China brachytherapy market databook
-
Our clientele includes a mix of brachytherapy market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China brachytherapy market , including forecasts for subscribers. This country databook contains high-level insights into China brachytherapy market from 2017 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
China brachytherapy market size, by dosage type, 2017-2028 (US$M)
China Brachytherapy Market Outlook Share, 2020 & 2028 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
